Jasper Therapeutics Faces Critical Phase 2b Junction in CSU Amid Financial & Regulatory Pressure
Jasper Therapeutics went public via a Septemb...
In 2025, a suspected defective drug-product l...
Urticaria data remain encouraging in higher-d...
Cash runway is constrained despite financings...
In 2025, a suspected defective drug-product l...
Urticaria data remain encouraging in higher-d...
Cash runway is constrained despite financings...










